Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage

Arthritis and Rheumatism

Volumn 52, Issue 1, 2005, Pages 333-338

  De Silva, Swanthri ^a   Han, Shuhua ^a   Zhang, Xuejun ^a   Huston, David P ^a   Winoto, Astar ^b   Zheng, Biao ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; GLUCOCORTICOID; IMMUNOGLOBULIN G2A ANTIBODY; MONOCLONAL ANTIBODY CD3; NUCLEAR RECEPTOR NUR77; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; CELL LINE; COLLAGEN TYPE II; CYTOKINES; DNA-BINDING PROTEINS; FEMALE; IMMUNOGLOBULIN G; INCIDENCE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 12344267607     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20736     Document Type: Article

References (15)

1. Goldschmidt TJ, Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 1991;21:1327-30.
2. Yoshino S, Cleland LG, Mayrhofer G. Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the α/β T cell antigen receptors. Arthritis Rheum 1991;34:1039-47.
3. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis [review]. Immunol Rev 1990;118:193-232.
4. - T cells from rheumatoid arthritis patients. J Immunol 1998;161:1018-25.
5. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
6. Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997;99:439-46.
7. Cantwell MJ, Hua T, Zvaifler NJ, Kipps TJ. Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1997;40:1644-52.
8. Winoto A, Littman DR. Nuclear hormone receptors in T lymphocytes [review]. Cell 2002;109 Suppl:S57-66.
9. Woronicz JD, Calnan B, Ngo V, Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994;367:277-81.
10. Calanan BJ, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995;3:273-82.
11. Weih F, Ryseck RP, Chen L, Bravo R. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc Natl Acad Sci U S A 1996;93:5533-8.
12. b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000;30:1568-75.
13. Jonsson R, Tarkowski A, Klareskog L. A demineralization procedure for immunohistopathological use: EDTA treatment preserves lymphoid cell surface antigens. J Immunol Methods 1986;88:109-14.
14. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis [review]. Annu Rev Med 2000;51:207-29.
15. Mauritz NJ, Holmdahl R, Jonsson R, van der Meide PH, Scheyniu SA, Klareskog L. Treatment with γ-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 1988;31:1297-304.